Literature DB >> 6720931

A distributed model of peritoneal-plasma transport: theoretical considerations.

M F Flessner, R L Dedrick, J S Schultz.   

Abstract

Transport of water-soluble substances between the peritoneal cavity and the plasma was modeled with a distributed approach. The model includes diffusion and convection through tissue as well as membrane transport across blood capillaries, which are assumed to be distributed uniformly in the tissue. Lymphatic uptake via the diaphragm is also included. Transport in the remainder of the body is modeled by a system of compartments. The resulting system of mass balances and rate equations is solved numerically to provide predictions of peritoneal volume and concentrations in plasma, peritoneal fluid, and tissue surrounding the cavity. The model sensitivity is explored by varying key parameters to determine whether the changes would have a significant effect on model output. Key parameters include peritoneal surface area, tissue diffusivity, capillary permeability, tissue void fraction, and hydrostatic and osmotic pressures in the capillaries and interstitium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6720931     DOI: 10.1152/ajpregu.1984.246.4.R597

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

2.  The effect of convection on bidirectional peritoneal solute transport: predictions from a distributed model.

Authors:  J K Leypoldt; L W Henderson
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

3.  Quantification of tissue distribution of antibiotics by kinetic hysteresis analysis.

Authors:  U Ganzinger; K Neumann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Management of peritoneal carcinomatosis from colorectal cancer.

Authors:  Chukwuemeka U Ihemelandu; Perry Shen; John H Stewart; Konstantinos Votanopoulos; Edward A Levine
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

5.  Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis.

Authors:  Johann Morelle; Amadou Sow; Nicolas Hautem; Caroline Bouzin; Ralph Crott; Olivier Devuyst; Eric Goffin
Journal:  J Am Soc Nephrol       Date:  2015-01-30       Impact factor: 10.121

6.  Co-trimoxazole (sulphamethoxazole plus trimethoprim) peritoneal barrier transfer pharmacokinetics.

Authors:  J E Svirbely; A J Pesce; S Singh; E J O'Flaherty
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

7.  Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy.

Authors:  Dhaval K Shah; Beom Soo Shin; Jean Veith; Karoly Tóth; Ralph J Bernacki; Joseph P Balthasar
Journal:  J Pharmacol Exp Ther       Date:  2009-02-20       Impact factor: 4.030

Review 8.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence.

Authors:  Wim P Ceelen; Michael F Flessner
Journal:  Nat Rev Clin Oncol       Date:  2009-12-15       Impact factor: 66.675

9.  Surgical management of carcinomatosis from colorectal cancer.

Authors:  Paul H Sugarbaker
Journal:  Clin Colon Rectal Surg       Date:  2005-08

10.  Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer.

Authors:  M G Wientjes; R A Badalament; J L Au
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.